{"id":"https://openalex.org/W7222848431","doi":"https://doi.org/10.1093/ofid/ofag679","title":"Safety and Immunogenicity of an mRNA Respiratory Syncytial Virus Vaccine, mRNA-1345, in Healthy and High-Risk Pediatric Populations Aged 2 to 17 Years","display_name":"Safety and Immunogenicity of an mRNA Respiratory Syncytial Virus Vaccine, mRNA-1345, in Healthy and High-Risk Pediatric Populations Aged 2 to 17 Years","publication_year":2026,"publication_date":"2026-10-13","ids":{"openalex":"https://openalex.org/W7222848431","doi":"https://doi.org/10.1093/ofid/ofag679","pmid":"https://pubmed.ncbi.nlm.nih.gov/42979232","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13728700"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofag679","doi":"https://doi.org/10.1093/ofid/ofag679","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag679","pdf_url":"https://academic.oup.com/ofid/article-pdf/13/11/ofag679/72066282/ofag679.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/13/11/ofag679/72066282/ofag679.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5158968036","display_name":"Jennifer Moore","orcid":"https://orcid.org/0009-0001-1828-2152","observed_orcids":["https://orcid.org/0009-0001-1828-2152"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jennifer Moore","raw_affiliation_strings":["Moderna Biotech Manufacturing UK Ltd , London ,"],"raw_orcid":"https://orcid.org/0009-0001-1828-2152","affiliations":[{"raw_affiliation_string":"Moderna Biotech Manufacturing UK Ltd , London ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023102506","display_name":"Hui Qian","orcid":"https://orcid.org/0000-0002-4206-7532","observed_orcids":["https://orcid.org/0000-0002-4206-7532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hui Qian","raw_affiliation_strings":["Moderna, Inc. , Cambridge, Massachusetts ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moderna, Inc. , Cambridge, Massachusetts ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003192771","display_name":"Sonia Stoszek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sonia K Stoszek","raw_affiliation_strings":["Moderna, Inc. , Cambridge, Massachusetts ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moderna, Inc. , Cambridge, Massachusetts ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158961953","display_name":"Richard Bennett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Bennett","raw_affiliation_strings":["Clinical Research Partners , Richmond, Virginia ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Partners , Richmond, Virginia ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032143222","display_name":"Shelly David Senders","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shelly Senders","raw_affiliation_strings":["Senders Pediatrics , South Euclid, Ohio ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Senders Pediatrics , South Euclid, Ohio ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002112506","display_name":"Scott P. Striplin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138040","display_name":"Velocity Clinical Research (United States)","ror":"https://ror.org/04nh35860","country_code":"US","type":"company","lineage":["https://openalex.org/I4210138040"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Striplin","raw_affiliation_strings":["Velocity Clinical Research , New Orleans, Louisiana ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Velocity Clinical Research , New Orleans, Louisiana ,","institution_ids":["https://openalex.org/I4210138040"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005095813","display_name":"Jennifer Lynn Nayak","orcid":"https://orcid.org/0000-0002-5042-3031","observed_orcids":["https://orcid.org/0000-0002-5042-3031"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer L Nayak","raw_affiliation_strings":["Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Rochester Medical Center , Rochester, New York ,"],"raw_orcid":"https://orcid.org/0000-0002-5042-3031","affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Rochester Medical Center , Rochester, New York ,","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030730584","display_name":"Matthew D. Snape","orcid":"https://orcid.org/0000-0003-0531-5426","observed_orcids":["https://orcid.org/0000-0003-0531-5426"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Matthew D Snape","raw_affiliation_strings":["Moderna Biotech Manufacturing UK Ltd , London ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moderna Biotech Manufacturing UK Ltd , London ,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5030730584","https://openalex.org/A5158968036"],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.79088472,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":"11","first_page":"ofag679","last_page":"ofag679"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/respiratory-syncytial-virus","display_name":"respiratory syncytial virus","score":0.9610000252723694},{"id":"https://openalex.org/keywords/mrna-vaccines","display_name":"mRNA vaccines","score":0.8989999890327454},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.7829999923706055},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8479999899864197},{"id":"https://openalex.org/keywords/reactogenicity","display_name":"reactogenicity","score":0.8679999709129333},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8220000267028809},{"id":"https://openalex.org/keywords/rsv-surveillance","display_name":"RSV surveillance","score":0.597000002861023},{"id":"https://openalex.org/keywords/lower-respiratory-tract-infection","display_name":"lower respiratory tract infection","score":0.7710000276565552},{"id":"https://openalex.org/keywords/at-risk-children","display_name":"vulnerable children","score":0.6359999775886536},{"id":"https://openalex.org/keywords/childhood-immunization","display_name":"childhood immunization","score":0.5379999876022339},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9435999989509583},{"id":"https://openalex.org/C2777704310","wikidata":"https://www.wikidata.org/wiki/Q7300322","display_name":"Reactogenicity","level":4,"score":0.8680999875068665},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.7534999847412109},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5812000036239624},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5539000034332275},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5371000170707703},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.4975000023841858},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4666999876499176},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.4636000096797943},{"id":"https://openalex.org/C2776012195","wikidata":"https://www.wikidata.org/wiki/Q754447","display_name":"Respiratory tract infections","level":3,"score":0.4456000030040741},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.41999998688697815},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.397599995136261},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.36010000109672546},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.3580000102519989},{"id":"https://openalex.org/C2781445406","wikidata":"https://www.wikidata.org/wiki/Q24802277","display_name":"Pneumovirinae","level":5,"score":0.34459999203681946},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3352999985218048},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3294999897480011},{"id":"https://openalex.org/C22889606","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Antibody titer","level":4,"score":0.3206000030040741},{"id":"https://openalex.org/C2779644171","wikidata":"https://www.wikidata.org/wiki/Q13400765","display_name":"Respiratory tract","level":3,"score":0.31709998846054077},{"id":"https://openalex.org/C2776399701","wikidata":"https://www.wikidata.org/wiki/Q3631290","display_name":"Lower respiratory tract infection","level":4,"score":0.3077000081539154},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.26190000772476196},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.2605000138282776},{"id":"https://openalex.org/C2780355102","wikidata":"https://www.wikidata.org/wiki/Q1753162","display_name":"Mononegavirales","level":5,"score":0.25850000977516174}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofag679","doi":"https://doi.org/10.1093/ofid/ofag679","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag679","pdf_url":"https://academic.oup.com/ofid/article-pdf/13/11/ofag679/72066282/ofag679.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13728700","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13728700/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13728700/pdf/ofag679.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"},{"id":"pmid:42979232","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42979232","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open forum infectious diseases","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofag679","doi":"https://doi.org/10.1093/ofid/ofag679","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag679","pdf_url":"https://academic.oup.com/ofid/article-pdf/13/11/ofag679/72066282/ofag679.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G6396280791","display_name":null,"funder_award_id":"GPP 2022","funder_id":"https://openalex.org/F4320319071","funder_display_name":"Moderna"}],"funders":[{"id":"https://openalex.org/F4320319071","display_name":"Moderna","ror":"https://ror.org/01xm4wg91"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7222848431.pdf","grobid_xml":"https://content.openalex.org/works/W7222848431.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W2567976091","https://openalex.org/W2659751330","https://openalex.org/W3046024889","https://openalex.org/W3131199387","https://openalex.org/W4214852692","https://openalex.org/W4281385327","https://openalex.org/W4362636468","https://openalex.org/W4389031085","https://openalex.org/W4389660759","https://openalex.org/W4391442706","https://openalex.org/W4392028959","https://openalex.org/W4394019141","https://openalex.org/W4405336123","https://openalex.org/W4411025928","https://openalex.org/W4411977529","https://openalex.org/W4414195712"],"related_works":["https://openalex.org/W4406954772","https://openalex.org/W7084050560","https://openalex.org/W4411025928","https://openalex.org/W4311615638","https://openalex.org/W4391442706","https://openalex.org/W4392028959","https://openalex.org/W4405336123","https://openalex.org/W4402379432","https://openalex.org/W4389031085","https://openalex.org/W4414483266"],"abstract_inverted_index":{"Background:":[0],"Respiratory":[1],"syncytial":[2],"virus":[3],"(RSV)":[4],"is":[5,23,29],"a":[6,49,131],"leading":[7],"cause":[8],"of":[9,52,133],"lower":[10],"respiratory":[11],"tract":[12],"infections":[13,191],"(LRTIs)":[14],"in":[15,54,130,173],"infants":[16],"and":[17,111,154,175,180],"children.":[18,27],"No":[19],"active":[20],"RSV":[21,33,77,120,190],"vaccine":[22,34],"currently":[24],"available":[25],"for":[26],"mRNA-1345":[28,53,90,157,169],"an":[30],"investigational":[31],"mRNA-based":[32],"encoding":[35],"the":[36,115,137],"prefusion":[37],"F":[38],"(preF)":[39],"glycoprotein.":[40],"Method:":[41],"This":[42],"phase":[43],"2,":[44],"randomized,":[45],"observer-blind":[46],"study":[47,149],"evaluated":[48],"single":[50],"dose":[51,152],"children":[55,94],"aged":[56,80,95],"2":[57,81],"to":[58,65,82,97,126,139],"<18":[59,98],"years":[60,67,84,99],"who":[61],"were":[62,192],"healthy":[63],"(2":[64],"<5":[66,83],"only)":[68],"or":[69,88,91,103,167],"had":[70],"stable":[71],"chronic":[72],"conditions":[73],"associated":[74],"with":[75,161,194],"increased":[76],"risk.":[78],"Children":[79],"received":[85,100,148],"7.5-,":[86],"15-,":[87,101],"30-\u00b5g":[89],"placebo,":[92],"whereas":[93],"5":[96],"30-,":[102],"50-\u00b5g":[104],"mRNA-1345.":[105],"The":[106],"primary":[107],"objective":[108,117],"was":[109,118,122,158],"safety":[110],"reactogenicity":[112],"(Part":[113,142],"A);":[114],"secondary":[116],"immunogenicity.":[119],"surveillance":[121],"conducted":[123],"from":[124,136],"6":[125],"12":[127],"months":[128],"post-immunization":[129],"subset":[132],"re-enrolled":[134],"participants":[135,147],"2-":[138],"<5-year-old":[140],"cohort":[141],"B).":[143],"Results:":[144],"Overall,":[145],"346":[146],"vaccination.":[150],"Across":[151],"levels":[153],"age":[155],"cohorts,":[156],"well":[159],"tolerated,":[160],"no":[162,195],"vaccine-related":[163],"serious":[164],"adverse":[165],"events":[166],"discontinuations.":[168],"elicited":[170],"robust":[171],"increases":[172],"RSV-A":[174],"RSV-B":[176],"neutralizing":[177],"antibody":[178],"titers":[179],"preF-biased":[181],"responses":[182],"by":[183],"day":[184],"29.":[185],"During":[186],"Part":[187],"B":[188],"surveillance,":[189],"infrequent,":[193],"severe/hospitalized":[196],"RSV-LRTIs.":[197],"Conclusions:":[198],":":[199],"NCT06097299.":[200]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-18T00:00:00"}